Authors are requested to be aware of the journal’s policies before making the submission
Editorial committee comprising a team of experienced professionals is committed to providing a unified service for both authors and reviewers. The journal follows the International Committee of Medical Journal Editors’ (ICMJE) recommendations for the conduct, reporting, editing and publication of scholarly work in medical journals (https://www.icmje.org/recommendations/) and adheres to publishing ethics guidelines published by Committee on Publication Ethics ( COPE) . The MARKS Medical Journal (MMJ) requires corresponding authors to complete an Author Statement on behalf of all co-authors before acceptance of the manuscript.
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by at least two anonymous reviewers and the Editor. Final acceptance or rejection rests with the Editorial Board, which reserves the right to refuse any material for publication. Manuscripts should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor and the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader.
An article is reviewed for publication on the assumption that its contents have not been submitted simultaneously to another journal, have not been accepted for publication elsewhere and have not already been published. Authors will be asked to confirm that that is the case during electronic submission process. Ant attempt at dual publication will lead to automatic rejection, may prejudice acceptance of future submissions, and may be highlighted within the pages of the journal.
Therefore authors need to submit their manuscript copies of any other papers ( including abstracts) – published , in press or submitted for consideration elsewhere- that relate in whole or in part to the same data set ; this is essential to enable assessment of any potential overlap by the editors.
Articles and illustrations become the property of the journal unless rights are reserved before publications.
Authors should ensure that they have written and submitted only entirely original works, and if they have used the work and/or words of others, that this has been appropriately cited. Plagiarism takes many forms, from “passing off” another’s paper as the author’s own, to copying or paraphrasing substantial parts of another’s paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable.
Authors should be aware that the MMJ uses “Turnitin” plagiarism detection software, to assure originality and integrity of material published in the Journal. All manuscripts submitted to The MARKS Medical Journal will undergo a plagiarism check with commercially available software. Based on the extent of plagiarism, authors may be asked to address any minor duplication or similarity with the previously published work. If plagiarism is detected after publication, the journal will investigate. If plagiarism is established, the journal will notify the authors’ institutions and funding bodies and retract the plagiarized article. So the use of copied sentences, even when present within quotation marks, is highly discouraged. Instead, the information of the original research should be expressed by new manuscript author’s own words, and a proper citation given at the end of the sentence. More than 25% Plagiarism will not be tolerated and manuscripts will be rejected, or papers withdrawn after publication based on unethical actions by the authors. In addition, authors may be sanctioned for future publication.
Papers that fundamentally describe the same study should not be published in more than one journal or primary publication. As a result, authors should not submit an article that has previously been published in another journal for consideration. Submission of a manuscript to more than one journal at the same time is unethical and unacceptable publishing behavior.
Specific types of papers (such as clinical recommendations or guidelines) may be published in more than one journal if certain requirements are satisfied. The authors and editors of the relevant journals must consent to secondary publication, which must have the same data and interpretation as the initial paper. In the secondary publication, the primary reference must be cited.
This policy establishes guidelines for the ethical transparent and responsible use of artificial intelligence (AI) and AI assisted technologies in a scholarly journal’s operations , publishing and editorial processes. The policy applies to authors, reviewer’s editors and journal staff.
MMJ is not in favour of use of AI generated scientific writing , but supports responsible use of AI in academic writing provided it adheres to the following principle –
Manuscript that fail to disclose AI usage or demonstrate ethical lapses will be subject to editorial action including rejection or retraction.
AI tools should be used as supportive instruments rather than as substitutes for critical thinking and original contributions. Authors must ensure that –
Authors must understand that – Misuse of AI , such as generating false citation or unverified information , constitutes academic misconduct and will lead to rejection of the manuscript.
For Authors
Authors are required to disclose the use of AI tools during manuscript preparation. AI tools should be used supportive instruments rather than as substitutes for critical thinking and original contributions . Authors must ensure that-
At submission, authors should disclose whether they use artificial intelligence (AI) – assisted technologies ( such as large language models (LLMs), chatbots or image creators) in the production of submitted work. Authors who used AI technology should describe, in both the Title page and a the at end of submitted manuscript. At the end of manuscript file before the references list , authors must disclose the use generative AI and AI assisted technologies in writing process by adding statement about how they use it and why they use it. The statement should be placed in a new section entitled “Declaration of Generated AI and AI-assisted technologies in the writing process.”
This declaration does not apply to the use basic tools for checking grammar, spelling, references etc. If there is nothing to disclose, there is no need to add a statement.
AI and AI assisted technologies cannot be listed as an author or co-author or to be cited as author. Authorship implies responsibilities and tasks that can only attributed to and performed by humans, as outlined in MMJ”s AI policy for authors. Authors remain responsible for-
Therefore, all authors should review and agree upon the AI assisted contribution before submission. They must ensure the use of AI does not compromise the scientific or ethical quality of the manuscript.
For Editors and Reviewers
Editors will use AI tools to assist in plagiarism and language editing. Such use will never replace human judgment of editors themselves. Beside this MRAKS Medical Journal does not use Generative AI or AI assisted technologies in the evaluation or decision making process of a manuscript. Managing editorial evaluation of a scientific manuscript implies responsibilities that can only attributed to humans. Because we believe critical thinking and original assessment needed for this work is beyond the capacity of this technology and there is a risk that the technology will generate incorrect, incomplete or biased conclusions about manuscripts.
Reviewers may use AI tools for language assistance but must not rely on AI tools to generate review content. Any such use must be disclosed to the editorial team.
If an editor suspects that an author or reviewer has violated our AI policies, then they should inform the publisher. Peer Reviewers should not upload manuscripts into generative AI tools. If any part of the evaluation of the claims made in the manuscript was in any way supported by an AI tool, we will ask peer reviewers to declare the use of such tools transparently in the peer review report.
In adherence to rigorous ethical standards, all research endeavors involving human subjects or human data within our esteemed MARKS Medical Journal (MMJ) undergo a meticulous evaluation, securing approval from a responsible Institutional Review Board (IRB). Researchers are strongly encouraged to align their investigations with the ethical principles outlined in the Declaration of Helsinki, providing a guiding framework for studies involving human materials (Declaration of Helsinki).
Upon request, authors are required to submit a statement from the IRB, or ethics committee, confirming the approval of their research. Our journal upholds the authority to decline work that falls short of the elevated ethical standards, even after formal approval has been granted. Participants involved in research must receive detailed instructions, expressing their informed consent by signing relevant documentation. Authors may also need to submit a sample copy of the subject consent form for thorough review. Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki(as revised in Brazil 2013), available at http://www.wma.net/en/30publications/10policies/b3/index.html.
All investigations on human subjects must include a statement that the subject gave informed consent. Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used). In general, submission of a case report should be accompanied by the written consent of the subject (or parent/guardian) before publication; this is particularly important where photographs are to be used or in cases where the unique nature of the incident reported makes it possible for the patient to be identified. While the Editorial Board recognizes that it might not always be possible or appropriate to seek such consent, the onus will be on the authors to demonstrate that this exception applies in their case.
In the case of animal experiments, approval must be sought from the authors’ Institutional Animal Care and Use Committee (IACUC) or equivalent ethics committee(s). Research must align meticulously with applicable national and international guidelines, securing approval before embarking on the research journey. Studies involving pathogens with elevated biosafety requirements should undergo review by a relevant committee (IBC), with detailed approval descriptions outlined in the manuscript’s Methods section. MARKS Medical Journal adheres to the guidelines established by the Committee on Publication Ethics (COPE), to address any instances of misconduct.
All participants, termed subjects, must undergo thorough instructions regarding the study’s objectives, procedures, and potential risks before participation. Their explicit consent is paramount, symbolized by their willingness to engage in the study through the endorsement of the informed consent paperwork. Authors aiming to publish their research outcomes may be requested to submit a sample of the subject consent form, a pivotal document delineating subjects’ comprehension and agreement to partake in the study.
To safeguard patient privacy and anonymity, authors are advised to follow the guidelines outlined by the International Committee of Medical Journal Editors (ICMJE) on Privacy and Confidentiality. These guidelines serve as a crucial framework for preserving the confidentiality of subjects’ personal information while ensuring transparent and accurate reporting of research findings.
Through unwavering commitment to these rigorous ethical considerations and privacy guidelines, researchers demonstrate their dedication to upholding the integrity of their studies, respecting the rights and well-being of their subjects, and thereby building trust and credibility within the scientific community.
Patient Rights
Patients have a right to privacy thus; all studies should be conducted with informed consent. No identifying information should be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. When informed consent has been obtained, it should be indicated in the article. Investigations with human subjects must follow the ethical standards formulated in the Helsinki Declaration of 1964, revised in 2013. All the experiments should be approved by the institutional human experimentation committee or equivalent.
Clinical Trial Registry
The journal recommends that the clinical trials should be registered in a publicly accessible database. Authors should include the clinical trial registration numbers on all papers that report their results. The authors must adhere to the minimum set of recommendations for reporting randomized trials as described in “The CONSORT (CONsolidated Standards of Reporting Trials) 2010 guideline”.
Editors, editorial board members, authors, and reviewers keep confidential all details of the editorial and peer review processes for submitted manuscripts. Even the identities of the reviewers are not disclosed to the corresponding author. In addition, reviewers maintain the confidentiality of the manuscript.
Advertising Policy
The MARKS Medical Journal does not endorse any product or service marked as an advertisement or promoted by a sponsor in its publications.
Editorial content is not compromised by commercial or financial interests or by any specific arrangements with advertising clients or sponsors. The editorial board of the journal does not accept for consideration and does not print advertising articles (both on a reimbursable and free basis).
The authors of the scientific articles cannot link to ads using keywords.
Copyright Policy
The authors hold the copyright© of the published articles in accordance with the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) license. If the submitted article contains material already protected by prior copyright, the corresponding author must obtain written permission from the copyright holder to reproduce the material in the article, which should be submitted to the journal’s editorial office.
The author must also ensure that the article does not violate the privacy rights of any individual(s) or entities, contains no defamatory content, and that all factual statements are accurate and based on sound research. Furthermore, the author must affirm that following any procedure or treatment described in the article would not cause harm if done in accordance with the article’s instructions and warnings.
In the event of any breach of these warranties, the corresponding author is liable to compensate the journal for any associated costs, expenses, or damages. Additionally, the corresponding author releases the journal’s Editor(s)-in-Chief and the Editorial Board and Team from any legal liability pertaining to statements made in the manuscript, including but not limited to intentional or unintentional errors, omissions, copyright issues, or plagiarism. This release may also extend to third parties as deemed appropriate by the journal.
If the article contains material from other copyrighted sources or includes images or videos in which individuals or other identifiable features are recognizable, the author must inform the journal’s Editorial Office during the submission process.
The author is responsible for obtaining clearance, and if necessary, making payments to obtain permission to reproduce copyrighted material for print and online publication in perpetuity. Written evidence of securing such permissions from the right holders must be provided to the editors. Additionally, the author must include acknowledgments as required by relevant institutions.
MARKS Medical Journals’ content is published under the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0). CC BY-NC articles allow the author, and any non-commercial bodies, to reuse the material for non-commercial uses in any other way they choose, subject to being in accordance with the CC-BY-NC license, (See: http://creativecommons.org/licenses/by-nc/4.0.) without acquiring permission from MARKS Medical Journal.
CC BY-NC articles can be identified by the following statement that appears at the end of the article:
Conflicts of Interest/ Disclosure
A Declaration of Conflicting Interests policy outlines a formal requirement for authors to provide a statement or disclosure regarding any potential conflicts of interest. Conflicts arise when authors, reviewers, or editors have undisclosed interests that may affect their judgments, causing readers to feel misled if revealed later. MARKS Medical College Journal adheres to the uniform requirements on Conflicts of Interest set forth by the International Committee of Medical Journal Editors (ICMJE). Authors must declare any financial support or relationships that may pose conflict of interest by disclosing any financial arrangements they have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product, or any conflict relating to technology or methodology. The absence of any interest to disclose must also be stated. This information must be included on the title page/in the submission system when submitting the manuscript.
Conflicts of interest arise when an author (or their affiliated institution), reviewer, editor, or editorial board member has financial or personal associations with other individuals or organizations that may potentially influence their actions in a manner that could introduce bias. It is essential to recognize that the mere existence of such relationships does not necessarily indicate an actual conflict of interest. The potential for conflicts of interest can persist regardless of an individual’s belief in whether the relationship impacts their judgment. Financial relationships, such as employment, consultancies, stock ownership, honoraria, payment for expert testimony, and patents, are the most easily identifiable conflicts of interest and are likely to undermine the credibility of the journal, the authors, and the scientific value of the research (source: http://www.icmje.org/index.html).
Each manuscript submitted to the journal should include a section titled “Conflicts of interest,” where a statement regarding any conflicts of interest must be provided. The statement should contain the initials of the author(s) along with details of the conflicts of interest. The following examples illustrate the format in which the Conflicts of Interest statement should be presented in the manuscript: “Conflicts of Interest: We declare no conflict of interest.”
Policy on Article Processing Charges
MARKS Medical Journal is the official journal of MARKS Medical College, Dental Unit . It is an open access journal. MARKS Medical Journal is supported by article processing charges (APCs). Currently, all APCs are covered by the MARKS Medical Journal itself so there are no publication charges for authors for publication in MARKS Medical Journal.
Yes,Here is the contact information for MARKS Medical College-Dental Unit (Academic): 📞 +8801841101003 📞 09 611-772233
Currently, we do not offer formal student support services such as counseling, student associations, or mentoring programs. However, our faculty provides continuous guidance and support throughout the academic journey.
We are committed to providing high-quality dental education and shaping the future of dentistry. For more information about admissions or our programs, please contact our accounts department at MARKS Medical College.
Yes, we provide a digital communication service for parents and students. Currently, we send class attendance updates and student dues notifications to parents via mobile SMS and WhatsApp.
Yes, we have!
